Special Issue "Cell-Cell Communication and Extracellular Vesicles in Cancer"
Deadline for manuscript submissions: 31 May 2022.
Interests: cell death and proliferation; signal transduction; inflammation; fibrosis; and kidney injury and repair
Interests: cell-cell communication; Orai channels
Cell–cell communication, either through direct contact or indirectly, is critical for multiple cellular processes, such as proliferation, survival, differentiation, and transdifferentiation, and plays a fundamental role in maintaining the integrity of tissue structure and the cellular environment. Extracellular vesicles (EVs) are a group of nanosized lipid-bound vesicles derived from various cellular origins that play a key role in cell–cell communication. EV-mediated cell–cell communication is involved in multiple processes of tumorigenesis and metastasis. It not only affects tumor growth, metabolism, and survival but also facilitates the surrounding or distant non-tumor cells to form a protumor microenvironment. Notably, recent studies indicate that EVs have the potential to serve as a next-generation drug delivery platform for cancer treatment.
We invite authors to contribute original research articles, as well as review articles, of both in vitro and in vivo studies using animal and human models to this Special Issue on the mechanisms of cell–cell communication and EV-mediated tumorigenesis, metastasis, and antitumor treatment.
Dr. Kebin Hu
Dr. Yandong Zhou
Dr. Ling Lin
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.